23 New and approved therapies for lupus nephritis: Belimumab and voclosporin

23 New and approved therapies for lupus nephritis: Belimumab and voclosporin

Bibliographic Details
Main Author:	Richard Furie
Format:	Article
Language:	English
Published:	BMJ Publishing Group 2022-04-01
Series:	Lupus Science and Medicine

Similar Items

FDA approves belimumab for treatment of children with lupus nephritis
by: article Editorial
Published: (2022-10-01)

Voclosporin for Lupus Nephritis: A #NephJC Editorial on AURORA
by: Bourne Auguste, et al.
Published: (2021-11-01)

Prospects for the use of belimumab in lupus nephritis
by: N. L. Kozlovskaya, et al.
Published: (2021-08-01)

Belimumab for systemic lupus erythematosus – Focus on lupus nephritis
by: Marlene Plüß, et al.
Published: (2022-11-01)

1202 Voclosporin for Lupus Nephritis: Results of the Two-year AURORA 2 Continuation Study
by: Amit Saxena, et al.
Published: (2022-12-01)

Voclosporin: Unique Chemistry, Pharmacology and Toxicity Profile, and Possible Options for Implementation into the Management of Lupus Nephritis
by: Ajinath Kale, et al.
Published: (2023-10-01)

1110 Voclosporin is Effective in Achieving Proteinuria Treatment Targets in Lupus Nephritis Defined by EULAR/ERA Recommendations
by: Hans-Joachim Anders, et al.
Published: (2022-12-01)

Urine proteomic insights from the belimumab in lupus nephritis trial
by: Daniel Goldman, et al.
Published: (2022-10-01)

Efficacy and safety of belimumab therapy in lupus nephritis: a systematic review and meta-analysis
by: Han Zhang, et al.
Published: (2023-12-01)

P90 Use of belimumab in patients with lupus nephritis refractory to standard treatment
by: Debasish Pyne, et al.
Published: (2024-03-01)

P91 Effective treatment of lupus nephritis and vasculitic fibrinoid necrotic ulcer with belimumab as add-on therapy
by: Azeem Ahmed, et al.
Published: (2024-03-01)

Rituximab Followed by Belimumab Controls Severe Lupus Nephritis and Bullous Pemphigoid in Systemic Lupus Erythematosus Refractory to Several Combination Therapies
by: Luca Petricca, et al.
Published: (2020-10-01)

Serum IFN-γ Predicts the Therapeutic Effect of Belimumab in Refractory Lupus Nephritis Patients
by: Liu S, et al.
Published: (2024-09-01)

I15 Targeting type I interferon in SLE and lupus nephritis
by: Richard Furie
Published: (2024-03-01)

Efficacy and safety of belimumab in lupus nephritis patients: a real-world observational study in China
by: Meng Tan, et al.
Published: (2023-02-01)

23 Refractory lupus nephritis
by: Sandra Navarra
Published: (2020-09-01)

Belimumab and low-doses of mycophenolate mofetil as induction therapy of class IV lupus nephritis: case series and literature review
by: Domenico Paolo Emanuele Margiotta, et al.
Published: (2018-03-01)

Belimumab in systemic lupus erythematosus
by: Ankita Srivastava
Published: (2016-01-01)

BELIMUMAB: ADVANCES IN DRUG THERAPY FOR SYSTEMIC LUPUS ERYTHEMATOSUS
by: Evgeny Lvovich Nasonov, et al.
Published: (2012-10-01)

Efficacy and safety of belimumab therapy for patients with lupus nephritis: A meta‐analysis and a propensity score‐matched case–control study
by: Kai Zhang, et al.
Published: (2023-07-01)

Effectiveness and safety of Belimumab combined with standard therapy in severe active lupus nephritis requiring kidney replacement therapy: A case report and literature review
by: Chengning Zhang, et al.
Published: (2022-09-01)

Long-term belimumab therapy in patients with systemic lupus erythematosus
by: A. A. Mesnyankina, et al.
Published: (2024-08-01)

Sequential therapy with rituximab and belimumab in patients with systemic lupus erythematosus
by: A. A. Mesnyankina, et al.
Published: (2020-11-01)

Belimumab versus telitacicept in sequential treatment after rituximab for refractory lupus nephritis: a real-world multicentre study
by: Fei Han, et al.
Published: (2025-01-01)

Clinical outcomes in lupus nephritis patients treated with belimumab in real-life setting: a retrospective comparative study in China
by: Zishan Lin, et al.
Published: (2024-09-01)

1104 Effects of Belimumab (BEL) on Renal Outcomes in Patients (pts) With Relapsed and Newly Diagnosed Active Lupus Nephritis (LN)
by: Brad H Rovin, et al.
Published: (2022-12-01)

PO.5.102 Pharmacokinetic modelling of belimumab in patients with lupus nephritis: intravenous and subcutaneous loading dose regimen justification
by: Y Green, et al.
Published: (2022-10-01)

Efficacy of Belimumab for active lupus nephritis in a young Hispanic woman intolerant to standard treatment: a case report
by: Francesco Fontana, et al.
Published: (2018-10-01)

PO.5.105 The effect of belimumab on extra-renal outcomes: results from the phase 3, randomised, placebo-controlled, 104-week bliss-ln study in patients with active lupus nephritis
by: M Okada, et al.
Published: (2022-10-01)

12 Belimumab helps lupus patients to achieve lupus targets
by: Andrea Doria
Published: (2020-09-01)

1007 Voclosporin for lupus nephritis: assessment of long-term safety and efficacy including renal outcome over three years of treatment in the phase 3 AURORA 1 and AURORA 2 studies
by: Cristina Arriens, et al.
Published: (2024-05-01)

Pharmacoeconomic analysis of rituximab and belimumab therapy in patients with systemic lupus erythematosus
by: D. A. Gerasimova, et al.
Published: (2024-10-01)

Efficacy of initial combination with belimumab in newly diagnosed childhood-onset lupus nephritis: a single-centre historical control study
by: Yu Shi, et al.
Published: (2024-12-01)

Combination of anti-SSA/Ro60 and anti-dsDNA serotype is predictive of belimumab renal response in patients with lupus nephritis
by: Jing Zhu, et al.
Published: (2024-05-01)

PO.5.116 Lupus nephritis response in terms of kidney function, urine sediment and serological activity after belimumab treatment
by: JA Roman Ivorra, et al.
Published: (2022-10-01)

EXPERIENCE WITH BELIMUMAB IN PATIENTS WITH SYSTEMIC LUPUS ERYTHEMATOSUS
by: E. A. Aseeva, et al.
Published: (2015-09-01)

New treatment options for lupus &ndash; a focus on belimumab
by: Chiche L, et al.
Published: (2012-01-01)

New possibilities of pharmacotherapy for systemic lupus erythematosus: A place of belimumab
by: E. L. Nasonov
Published: (2014-12-01)

Individualizing Therapy in Lupus Nephritis
by: Yu An, et al.
Published: (2019-10-01)

Effectiveness and safety of belimumab in Chinese adult lupus nephritis patients: a 24-week retrospective single-center real-world study
by: Pei-pei Jiang, et al.
Published: (2024-07-01)